|Articles|October 1, 2016
- Pharmaceutical Executive-10-01-2016
- Volume 36
- Issue 10
Pharmaceutical Executive, October 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive October 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Content Marketing’s Data Fail: Information Without Insight?over 9 years ago
The Rise of the CFO Strategist: Balancing Numbers and Know-howover 9 years ago
Steps Toward Rare Disease Successover 9 years ago
‘Huge Sellers’ Herald Changes in Japan Drug Pricingover 9 years ago
Real-World Evidence: From Volume to Valueover 9 years ago
Pharma and the Peril of Europe’s Trade Policiesover 9 years ago
New Challenge to IP Innovationover 9 years ago
Major Changes Ahead for Drug User Feesover 9 years ago
Country Report: Czech RepublicAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
What Pharma Investors Should Expect in the Current Regulatory Environment
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5